Comparing diagnostic tests on benefit-risk

References

• Baker, S. G. (2009). Putting risk into perspective: Relative utility curves. Journal of the National Cancer Institute 101:1538–1542.
   PubMedGoogle Scholar
• Baker, S. G., Cook, N. R., Andrew Vickers, A., Kramer, B. S. (2009). Using relative utility curves to evaluate risk prediction. Journal of the Royal Statistical Society A 172(4):729–748.
   PubMed Web of Science ®Google Scholar
• Baker, S. G., Kramer, B. S. (2012). Evaluating a new marker for risk prediction: Decision analysis to the rescue. Discovery Medicine 14(76):181–188.
   PubMed Web of Science ®Google Scholar
• Baker, S. G., Van Calster, B., Steyerberg, E. W. (2012). Evaluating a new marker for risk prediction using the test tradeoff: An update. The International Journal of Biostatistics 8(1): Article 5.
   PubMedGoogle Scholar
• Biggerstaff, B. J. (2000). Comparing diagnostic tests: A simple graphic using likelihood ratios. Statistics in Medicine 19:649–663.
   PubMed Web of Science ®Google Scholar
• Bossuyt, P. M., Lijmer, J. G., Mol, B. W. (2000). Randomised comparisons of medical tests: Sometimes invalid, not always efficient. Lancet 356:1844–1847.
   PubMed Web of Science ®Google Scholar
• Cook, N. R. (2007). Use and misuse of the receiver operating characteristics curve in risk prediction. Circulation 115(7):928–935.
   PubMed Web of Science ®Google Scholar
• Deneef, P., Kent D. (1993). Using treatment-tradeoff preferences to select diagnostic strategies: Linking the ROC curve to threshold analysis. Medical Decision Making 13:126–132.
   PubMed Web of Science ®Google Scholar
• Evans, S. R., Pennello, G., Pantoja-Galicia, N., Jiang, H., Hujer, A. M., Hujer, K. M., Manca, C., Hill, C., Jacobs, M. R., Chen, L., Patel, R., Kreiswirth, B. N., Bonomo, R. A., The Antibacterial Resistance Leadership Group (ARLG). (2016). Benefit-risk evaluation for diagnostics: A framework (BED-FRAME). Clinical Infectious Diseases 63(6):812–817. doi: 10.1093/cid/ciw329.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (2007). Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests: Guidance for Industry and FDA Reviewers (released March 13, 2007). http://www.fda.gov/RegulatoryInformation/Guidances/ucm071148.htm (accessed September 2016).
   Google Scholar
• Gail, M. H., Pfeiffer, R. M. (2005). On criteria for evaluating models of absolute risk. Biostatistics 6:227–239.
   PubMed Web of Science ®Google Scholar
• Hoering, A., Leblanc, M., Crowley, J. (2008). Randomized Phase III clinical trial designs for targeted agents. Clinical Cancer Research 14(14):4358–4367. [ PubMed: 18628448]
   PubMed Web of Science ®Google Scholar
• McIntosh, M. W., Pepe, M. S. (2002). Combining several screening tests: Optimality of the risk score. Biometrics 58:657–664.
   PubMed Web of Science ®Google Scholar
• Metz, C. E. (1978). Basic principles of ROC analysis. Seminars in Nuclear Medicine 8(4):283–298.
   PubMed Web of Science ®Google Scholar
• Pauker, S. G., Kassirer, J. P. (1975).Therapeutic decision making: A cost-benefit analysis. New England Journal Medicine 293:229–234.
   PubMed Web of Science ®Google Scholar
• Pepe, M. S., Janes, H., Li, C. I., Bossuyt, P. M., Feng, Z., Hilden J. (2016). Early-phase studies of biomarkers: What target sensitivity and specificity values might confer clinical utility? Clinical Chemistry 62:737–742.
   PubMed Web of Science ®Google Scholar
• Pepe, M. S., Janes, H., Longton, G., Leisenring, W., Newcomb, P. (2004). Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. American Journal of Epidemiology 159(9):882–890.
   PubMed Web of Science ®Google Scholar
• Simon, R. (2010) Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology. Personalized Medicine 7(1):33–47. doi:10.2217/pme.09.49.
   PubMed Web of Science ®Google Scholar
• Tsalik, E. L., Li, Y., Hudson, L. L., Chu, V. H., Himmel, T., Limkakeng, A. T., Katz, J. N., Glickman, S. W., McClain, M. T., Welty-Wolf, K. E., Fowler, V. G., Ginsburg, G. S., Woods, C. W., Reed, S. D. (2016). Potential cost-effectiveness of early identification of hospital-acquired infection in critically Ill patients. Annals of the American Thoracic Society 13(3):401–413.
   PubMed Web of Science ®Google Scholar
• Rutter, C. M., Johnson, E., Miglioretti, D. L., Mandelson, M. T., Inadomi, J., Buist, D. S.M (2012). Adverse events after screening and follow-up colonoscopy. Cancer Causes Control 23:289–296.
   PubMed Web of Science ®Google Scholar
• Vickers, A. J., Elkin, E. B. (2006). Decision curve analysis: A novel method for evaluating prediction models. Medical Decision Making 26:565–574.
   PubMed Web of Science ®Google Scholar
• Zweig, M. H., Campbell, G. (1993). Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clinical Chemistry 39(4):561–577.
   PubMed Web of Science ®Google Scholar